Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data

Authors :: Samuel H. Zwillich
Yoshiya Tanaka
Naonobu Sugiyama
Hisashi Yamanaka
Tomohiro Hirose
Kunihiro Yamaoka
Shoko Arai
Ryan DeMasi
Tsutomu Takeuchi
Yuri Fukuma
Shigeyuki Toyoizumi
Source :: Modern Rheumatology. 29:756-766
Publication Year :: 2019
Publisher :: Oxford University Press (OUP), 2019.
Abstract: Objectives: Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis (RA). We investigated concomitant methotrexate (MTX) dose on tofacitinib efficacy/safety in Japanese RA pa...

Tools